[ Price : $8.95]
FDA approves a LimFlow PMA for its LimFlow System for treating patients with chronic limb-threatening ischemia who have no other s...[ Price : $8.95]
FDA issues its first Postmarket Device Safety-Related Communications report to Congress that details 45 safety-related communicati...[ Price : $8.95]
The Department of Justice petitions the U.S. Supreme Court asking it to reverse last months decision by the Fifth Circuit Court of...[ Price : $8.95]
FDA gives the green light for updated Covid-19 vaccines manufactured by ModernaTX and Pfizer that are formulated to more closely t...[ Price : $8.95]
AstraZeneca says data from its FLAURA2 Phase 3 trial showed that Tagrisso (osimertinib) plus chemotherapy in lung cancer patients ...[ Price : $8.95]
FDA and Duke-Margolis Center for Health Policy announce a 9/18-19 two-day public workshop to discuss pregnancy safety studies.[ Price : $8.95]
Federal Register notice: FDA seeks participation by industry organizations in selecting nonvoting industry representatives to serv...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Institutional Review Board (IRB) Review of Individual Patie...